Dr. Ott’s research focuses on two pathogens—human immunodeficiency virus (HIV-1) and hepatitis C virus (HCV)—and three cellular processes—transcriptional elongation, lipid droplets, and immune aging. Her research is relevant for efforts to eradicate HIV from patients, to alleviate fatty liver disease in patients with HCV infection and suppress autoimmunity in patients with type I diabetes. Dr. Ott joined Gladstone in 2002. In 1999 and 2000, Dr. Ott was honored with the Young Researcher Award at the European Conference on Experimental AIDS Research. In 2006, she won the Hellman Award, established by F. Warren Hellman at UCSF to support the research of promising assistant professors with the capacity for great distinction in their research. She is also a recipient of the Chancellor’s Award for Public Service with UCSF for her work on promoting science education in local schools and specifically targeting underserved youth. Dr. Ott is a member of many scientific and professional societies, including the Association of American Physicians. She served until recently as a permanent member of the AIDS Molecular Cellular Biology study section at the National Institutes of Health and is a member of scientific advisory boards of several scientific institutions, including the Pette Institute of Virology and the Helmholtz organization in Germany. Prior to joining Gladstone, Dr. Ott started her own research group at the German Cancer Research Center (DKFZ) in Heidelberg, Germany.
« Go Back